Low serum albumin levels and in-hospital outcomes in patients with ST segment elevation myocardial infarction

• Published in: Nutrition, metabolism, and cardiovascular diseases Vol. 31; no. 10; pp. 2904 - 2911
• Main Authors: Bicciré, Flavio Giuseppe, Pastori, Daniele, Tanzilli, Alessandra, Pignatelli, Pasquale, Viceconte, Nicola, Barillà, Francesco, Versaci, Francesco, Gaudio, Carlo, Violi, Francesco, Tanzilli, Gaetano
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 22.09.2021
• Subjects: Cardiogenic shock; Hypoalbuminemia; Mortality; STEMI; CRP; LCX; NSTEMI; HORIZONS-AMI; HR; SA; AEs; ARIC; Cardiogenic shock; STEMI; WBC; cTnT; Hb; CA; eGFR; cTFC; OR; Mortality; CI; GP; LAD; Hypoalbuminemia; VF; RCA; ACS; pPCI; TIMI; ROS; HS-TnT; LMCA; VT; HF
• ISSN: 0939-4753; 1590-3729
• DOI: 10.1016/j.numecd.2021.06.003

Low serum albumin (SA) is associated with an increased risk of long-term adverse events (AEs) among patients with chronic coronary syndromes. Its prognostic role in patients with ST-elevation myocardial infarction (STEMI) is less clear. To investigate the association between low SA and in-hospital AEs in STEMI patients. Multicenter retrospective cohort study of 220 STEMI patients undergoing primary percutaneous coronary intervention within 12 h from the onset of symptoms. Hypoalbuminemia was defined by serum SA <35 g/L. SA. In-hospital AEs were defined as cardiogenic shock, resuscitated cardiac arrest and death. Median SA was 38 (IQR 35.4–41.0) g/L and 37 (16.8%) patients showed hypoalbuminemia (<35 g/L) on admission. Patients with hypoalbuminemia were older, more frequently women and diabetics, prior CAD and HF. Furthermore, they showed lower hemoglobin levels and impaired renal function. At multivariable logistic regression analysis, diabetes (odds ratio [OR]:4.59, 95% confidence interval [CI] 1.71–12.28, p = 0.002) and haemoglobin (OR:0.52, 95%CI 0.37–0.72, p < 0.001) were associated with low SA. In a subgroup of 132 patients, SA inversely correlated with D-Dimer (rS −0.308, p < 0.001). Globally, twenty-eight (14.6%) AEs were recorded. Hypoalbuminemia (OR:3.43, 95%CI 1.30–9.07, p = 0.013), high-sensitive (HS)-Troponin peak above median (OR:5.41, 95%CI 1.99–14.7, p = 0.001), C-reactive protein (CRP) peak above median (OR:6.03, 95%CI 2.02–18.00, p = 0.001), and in-hospital infection (OR:3.61, 95%CI 1.21–10.80, p = 0.022) were associated with AEs. Low SA levels are associated with worse in-hospital AEs in STEMI patients, irrespective of HS-troponin and CRP plasma levels. Our findings suggest that low SA may contribute to the pro-thrombotic phenotype of these patients. •Low SA correlates with adverse events in STEMI patients.•SA determinants are age, sex, diabetes, hemoglobin, prior heart and renal failure.•SA inversely correlates with D-Dimer levels.•Low SA may contribute to the pro-thrombotic phenotype of STEMI patients.